Showing results (71-80 of 319) with videos related to
Sort By:
Pageof 32
Journal of Cancer Prevention|April 9, 2015
Clinical Implication of p16, Ki-67, and Proliferating Cell Nuclear Antigen Expression in Cervical Neoplasia: Improvement of Diagnostic Accuracy for High-grade Squamous Intraepithelial Lesion and Prediction of Resection Margin Involvement on Conization SpecimenTae Hun Kim, Jee Hye Han, Eun Shin, et al.Oncology Letters|August 25, 2021
Identification of GNA12-driven gene signatures and key signaling networks in ovarian cancerJi-Hee Ha, Muralidharan Jayaraman, Mingda Yan, et al.Gynecologic Oncology|May 17, 2021
Prognostic implications of body composition change during primary treatment in patients with ovarian cancer: A retrospective study using an artificial intelligence-based volumetric techniqueSe Ik Kim, Soonho Yoon, Taek Min Kim, et al.The Journal of Obstetrics and Gynaecology Research|September 12, 2007
Efficacy and outcome of anterior vaginal wall repair using polypropylene mesh (Gynemesh)Hoenil Jo, Jae Weon Kim, Noh Hyun Park, et al.Metabolites|May 26, 2023
Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic StrategiesRevathy Nadhan, Srishti Kashyap, Ji Hee Ha, et al.Journal of Cancer Prevention|October 23, 2014
Cellular dynamics after injection of mesoderm-derived human embryonic kidney 293 cells and fibroblasts into developing chick embryosTae Sub Park, Jeong Mook Lim, Ki Hyun Kim, et al.Carcinogenesis|March 27, 2009
Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoproteinSu-Hyeong Kim, Jung-Min Oh, Jae-Hong No, et al.Carcinogenesis|December 15, 2006
GADD153 mediates celecoxib-induced apoptosis in cervical cancer cellsSu-Hyeong Kim, Chang-Il Hwang, Yong-Sung Juhnn, et al.Cancer Research and Treatment|April 25, 2013
Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian CancerHee Jun Lee, Hee Seung Kim, Noh Hyun Park, et al.Onkologie|June 13, 2008
Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancerHee Seung Kim, Noh-Hyun Park, Hyun Hoon Chung, et al.Pageof 32